This statistic shows a hypothetical example of physician office payments for biosimilars in Medicare Part B as of 2022. The wholesale acquisition cost (WAC) for the reference drug would be one thousand U.S. dollars, while the WAC for biosimilar A would be 200 dollars lower.
Example of physician office payment for biosimilars in Medicare Part B as of 2022
(in U.S. dollars)
This hypothetical example assumes that the reference biologic’s ASP (average sales price) is 20% less than the WAC (wholesale acquisition cost) based on rebates over time.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Amgen. (October 31, 2022). Example of physician office payment for biosimilars in Medicare Part B as of 2022 (in U.S. dollars) [Graph]. In Statista. Retrieved October 31, 2024, from https://www.statista.com/statistics/700131/physician-office-payment-for-biosimilars-in-medicare-part-b/
Amgen. "Example of physician office payment for biosimilars in Medicare Part B as of 2022 (in U.S. dollars)." Chart. October 31, 2022. Statista. Accessed October 31, 2024. https://www.statista.com/statistics/700131/physician-office-payment-for-biosimilars-in-medicare-part-b/
Amgen. (2022). Example of physician office payment for biosimilars in Medicare Part B as of 2022 (in U.S. dollars). Statista. Statista Inc.. Accessed: October 31, 2024. https://www.statista.com/statistics/700131/physician-office-payment-for-biosimilars-in-medicare-part-b/
Amgen. "Example of Physician Office Payment for Biosimilars in Medicare Part B as of 2022 (in U.S. Dollars)." Statista, Statista Inc., 31 Oct 2022, https://www.statista.com/statistics/700131/physician-office-payment-for-biosimilars-in-medicare-part-b/
Amgen, Example of physician office payment for biosimilars in Medicare Part B as of 2022 (in U.S. dollars) Statista, https://www.statista.com/statistics/700131/physician-office-payment-for-biosimilars-in-medicare-part-b/ (last visited October 31, 2024)
Example of physician office payment for biosimilars in Medicare Part B as of 2022 (in U.S. dollars) [Graph], Amgen, October 31, 2022. [Online]. Available: https://www.statista.com/statistics/700131/physician-office-payment-for-biosimilars-in-medicare-part-b/
